Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study

BACKGROUND: Major adverse cardiovascular events (MACE) cause the leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD) on maintenance Hemodialysis (HD) or peritoneal dialysis (PD). Many randomized-controlled trials (RCTs) have proved that angiotensin receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chung-Wei, Tzeng, Nian-Sheng, Yin, Yun-Ju, Li, Chien-Hsun, Chen, Hung-An, Chiu, Shih-Hsiang, Ho, Shinn-Ying, Huang, Hui-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619342/
https://www.ncbi.nlm.nih.gov/pubmed/26488749
http://dx.doi.org/10.1371/journal.pone.0140633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619342/
https://www.ncbi.nlm.nih.gov/pubmed/26488749
http://dx.doi.org/10.1371/journal.pone.0140633

Ejemplares similares